AngioDynamics Inc reports results for the quarter ended in November - Earnings Summary

AngioDynamics

05/01/2023 14:31

* AngioDynamics Inc  ANGO.OQ  reported quarterly adjusted
earnings
of 1 cent​​ per share for the quarter ended in November. The
mean expectation of four analysts for the quarter was for a loss
of one cent per share.
    * Revenue rose 9.1% to $85.43 million from a year ago;
analysts
expected $84.33 million. 
    * AngioDynamics Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The mean earnings estimate of analysts had fallen by
about 300%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AngioDynamics Inc shares had fallen by 1.2% this quarter.
    * The company reported a quarterly loss of $8.49 million.
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $25.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data January 5
at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Nov. 30 2022      -0.01          0.01           Beat
 Aug. 31 2022      -0.02          -0.06          Missed
 May. 31 2022      0.01           0.01           Met
 Feb. 28 2022      -0.01          0.03           Beat